Literature DB >> 3260951

Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. A role for overproduction of interleukin-2 in human autoimmunity?

R J Warrington1.   

Abstract

Interleukin-2 (IL-2) production in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) was assessed at varying cell densities from 3 X 10(3)-1 X 10(5) cells/culture in response to mitogen stimulation, using a cellular interleukin assay in which IL-2 responsive CTLL-2 indicator cells were added directly to stimulated peripheral blood lymphocyte cultures. It was found that in both RA and SLE there was a significant overproduction of IL-2 demonstrable at low cell densities. At high cell densities, IL-2 production was decreased in SLE but remained enhanced in RA. The former abnormality appears to be related to disease activity and was not reversed by irradiation, suggesting that it is not the result of the actions of a radiation sensitive suppressor cell population. The possibility is discussed that a local hyper-production of IL-2 could induce disturbances of the immune response, resulting in the breaking of normal tolerance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260951

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Phenotypic analysis of functionally associated molecules on peripheral blood and synovial fluid monocytes from arthritis patients.

Authors:  S J Gadd; T Felzmann; O Majdic; D Maurer; P Petera; W J Chen; J Smolen; W Knapp
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

Review 2.  Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.

Authors:  Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

3.  Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus.

Authors:  R J Warrington; W J Rutherford
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

4.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

Review 5.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Reversible interleukin-2 response defects in systemic lupus erythematosus.

Authors:  R J Warrington; P J Sauder; J Homik; W Ofosu-Appiah
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

Review 7.  Pathogenesis of systemic lupus erythematosus.

Authors:  C C Mok; C S Lau
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

8.  Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids.

Authors:  D Santoli; P D Phillips; T L Colt; R B Zurier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation.

Authors:  P Yaqoob; E A Newsholme; P C Calder
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.